- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Pegylated liposomal doxorubicin plus Bortezomib
Total 1300 results
-
Seoul National University HospitalUnknownHigh Grade Serous Carcinoma | Ovarian Neoplasm EpithelialKorea, Republic of
-
National Cancer Institute (NCI)CompletedDS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell MyelomaUnited States
-
Johnson & Johnson Pharmaceutical Research & Development...Centocor Ortho Biotech Services, L.L.C.Withdrawn
-
Millennium Pharmaceuticals, Inc.WithdrawnOvarian CancerItaly, Switzerland
-
National Cancer Institute (NCI)CompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Breast Carcinoma | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast Carcinoma | Male Breast Carcinoma | Stage IV Breast Cancer AJCC...United States
-
UNC Lineberger Comprehensive Cancer CenterMerck Sharp & Dohme LLC; Millennium Pharmaceuticals, Inc.; Ortho Biotech, Inc.TerminatedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedLymphoma | Leukemia | Breast Cancer | Ovarian Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
Joseph TuscanoMillennium Pharmaceuticals, Inc.CompletedAcute Myelogenous LeukemiaUnited States
-
French Innovative Leukemia OrganisationCompleted
-
Sun Yat-sen UniversityUnknown
-
University of RegensburgEssex Pharma GermanyCompleted
-
UNC Lineberger Comprehensive Cancer CenterMerck Sharp & Dohme LLCWithdrawnStudy of Vorinostat With Doxil and Bortezomib for Patients With Relapsed/Refractory Multiple MyelomaMultiple MyelomaUnited States
-
Tianjin Medical University Second HospitalCSPC Pharmaceutical Group LimitedUnknownMuscle Invasive Bladder CancerChina
-
GlaxoSmithKlineCompletedNeoplasms, OvarianUnited States
-
M.D. Anderson Cancer CenterCompleted
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Clear Cell Cystadenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Serous Cystadenocarcinoma | Ovarian Undifferentiated CarcinomaUnited States
-
Herbert Irving Comprehensive Cancer CenterNational Cancer Institute (NCI)UnknownMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
MedSIRRoche Pharma AG; ExperiorCompleted
-
University of California, San FranciscoWithdrawn
-
Roswell Park Cancer InstituteCompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Cancer Institute and Hospital, Chinese Academy...CSPC Ouyi Pharmaceutical Co., Ltd.UnknownHER2-positive Breast CancerChina
-
Fudan UniversityRecruiting
-
Roswell Park Cancer InstituteNot yet recruitingAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Metastatic Triple-Negative Breast Carcinoma | Locally Advanced Unresectable Triple-Negative Breast CarcinomaUnited States
-
University of ArizonaTerminatedBreast CancerUnited States
-
Spanish Breast Cancer Research GroupSchering-PloughCompleted
-
European Organisation for Research and Treatment...CompletedLymphomaGermany, Switzerland, Israel, United Kingdom, Austria, Italy
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedSarcoma | Endometrial CancerUnited States, Canada
-
Janssen-Ortho Inc., CanadaCompleted
-
Roswell Park Cancer InstituteOrtho Biotech, Inc.Terminated
-
Yong ChenUnknownStage III Adult Soft Tissue SarcomaChina
-
AGC Biologics S.p.A.Completed
-
AGC Biologics S.p.A.CompletedOvarian CancerItaly, United Kingdom
-
University of LeicesterUnknownGastric Cancer | Esophageal CancerUnited Kingdom
-
ARCAGY/ GINECO GROUPCompleted
-
European Organisation for Research and Treatment...CompletedBreast CancerFrance, Spain, Netherlands, United Kingdom, Italy, Israel, Switzerland, Greece, Austria
-
National Cancer Institute (NCI)RecruitingMetastatic Leiomyosarcoma | Unresectable Leiomyosarcoma | Metastatic Sarcoma | Unresectable Soft Tissue Sarcoma | Metastatic Soft Tissue Sarcoma | Unresectable SarcomaUnited States
-
Merck Sharp & Dohme LLCCompleted
-
University of Wisconsin, MadisonNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Merck Sharp & Dohme LLCCompleted
-
Fudan UniversityNot yet recruiting
-
Merck Sharp & Dohme LLCTerminated
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedEndometrial CancerUnited States
-
ImunonCompletedProstate CancerUnited States
-
Case Comprehensive Cancer CenterRecruitingRelapsed SarcomasUnited States
-
Brown UniversityUnknownLiver Cancer | Gallbladder Cancer | Extrahepatic Bile Duct CancerUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)Completed
-
Janssen Research & Development, LLCCompletedMultiple MyelomaAustralia, France, Poland, United Kingdom, United States, Spain, Israel, Portugal, South Africa, Canada, Netherlands, Belgium, Singapore, Russian Federation, Czech Republic, Argentina, Austria
-
Swiss Group for Clinical Cancer ResearchCompletedBreast Cancer | Palmar-plantar ErythrodysesthesiaSwitzerland
-
Merck Sharp & Dohme LLCTerminated
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity Cancer